SCENTpart 2. Identification of patients with lung cancer and breast cancer.

Suspended

• Conditions: smell-printelectronic Noseexhaled breathlung cancerbreast cancer

• Registration Number: NL-OMON27863
• Lead Sponsor: MC

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

All patients (18-80 yr) referred to the outpatient department pulmonary diseases for suspicion of lung cancer and at the outpatient department of surgery for suspicion of breast cancer.

Exclusion Criteria

None, exept impossibillity to make a diagnosis or folow the instructions prior to the measurement.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity, specificity, positive and negative predictive value of the eNose in detecting NSCLC or breast cancer.

Secondary Outcome Measures

Name	Time	Method
Sensitivity, specificity, positive and negative predictive value of the eNose in detecting subtypes of NSCLC (adenocarcinoma or squamous cell carcinoma)